ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE) OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1 in Journal of Immunology
Transparency directive : regulatory news
02/04/2024 07:30
ORPHAN SYNERGY EUROPE-PHARMA's latest news
02/04/2024 07:30
18/03/2024 07:30
28/02/2024 07:30
19/01/2024 07:30
11/12/2023 07:30
27/09/2023 18:03
26/05/2023 08:15
12/05/2023 18:00
12/12/2022 07:30
03/11/2022 07:30
Other stories
30/04/2024 02:21
30/04/2024 05:36
Disability benefit claims can't be made on 'unverifiable assertions', argues Sunak - The Independent
30/04/2024 03:31
30/04/2024 06:03
30/04/2024 05:01
30/04/2024 06:06
30/04/2024 00:22
29/04/2024 18:37
29/04/2024 13:00
30/04/2024 06:46
30/04/2024 03:01
29/04/2024 16:25
30/04/2024 01:00
29/04/2024 20:19
29/04/2024 19:23
29/04/2024 22:03
29/04/2024 17:02
29/04/2024 17:40
29/04/2024 12:07
30/04/2024 02:22
29/04/2024 21:26
29/04/2024 18:58
29/04/2024 23:42
29/04/2024 07:00
30/04/2024 00:41
30/04/2024 01:28
29/04/2024 22:14
30/04/2024 00:20
29/04/2024 23:00
29/04/2024 22:35
29/04/2024 22:31
28/04/2024 19:21
29/04/2024 22:10
29/04/2024 16:26
30/04/2024 01:08
29/04/2024 18:25
30/04/2024 06:00
29/04/2024 18:18